SeQure® microcatheter could help to make embolisation more secure

Geert Maleux (Leuven, Belgium), one of the first users of the SeQure® reflux control microcatheter (Guerbet) in Europe, shares his experience with the new device. He tells BLearning IR that the current challenges of embolotherapy include incomplete devascularisation, which can occur in some cases of liver chemoembolisation procedures, as well as non-target embolisation.

Maleux shares that he was drawn to using the SeQure® microcatheter because it is a safe device that can help avoid complications such as non-target embolisation. “[.] I have also the impression that we can deliver more microparticles into the targeted areas, for instance in cases of liver chemoembolisation, into the tumour,” he adds.

Guerbet sponsored this video and its distribution in association with Interventional News.

Maleux, Geert

Geert Maleux graduated in 1991 as Doctor in Medicine, Surgery and Obstetrics (MD) at the Catholic University of Leuven, Belgium. After his residency in general radiology at the University Hospitals of Leuven (1991-1996 – Prof. A. Baert), he performed a one-year fellowship in interventional radiology (CHU Rangeuil Toulouse – Prof. F. Joffre & Prof. H. Rousseau). Since 1997, he is appointed staff interventional radiologist at the University Hospitals Leuven. In 2007, Geert Maleux succesfully finished his PhD-thesis on ‘Value of new diagnostic and interventional radiological techniques to improve clinical outcome of transjugular intrahepatic portosystemic shunts’ and became associate professor in Radiology at the Catholic University of Leuven in 2008.

He is an active member of several interventional radiological societies (CIRSE, SIR and GEST) and (co-) authored more than 200 publications on different aspects in interventional radiology.

Add comment

    Subscribe to receive the very best in medical videos

    /* ]]> */